financial post
Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair
Financial Post • 6 MONTHS AGO
InfoSec Global, a Keyfactor Company, Secures Second U.S. Patent for Cryptographic Agility
Financial Post • 6 MONTHS AGO
DP World Expands Logistics Footprint in Brazil with New Freight Forwarding Office in Porto Alegre
Financial Post • 6 MONTHS AGO
Sustained elevated inventories soften Fraser Valley home prices further, spurring bump in sales
Financial Post • 6 MONTHS AGO
Foremost Clean Energy Announces 3-Year Drill Permit for Hatchet Uranium Project and Plans for Upcoming 3,000 Metre Winter Drill Program
Financial Post • 6 MONTHS AGO
Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance
Financial Post • 6 MONTHS AGO